NIM
ALXN

NuWave Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

NuWave Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,127
Closed -$631K – 445
2021
Q1 		$631K Buy
+4,127
New +$638K 0.8% 29
2020
Q4 		– Sell
-12
Closed -$1K – 555
2020
Q3 		$1K Sell
12
-140
-92% -$15.1K ﹤0.01% 527
2020
Q2 		$17K Sell
152
-587
-79% -$62.3K 0.02% 288
2020
Q1 		$66K Sell
739
-3,217
-81% -$316K 0.14% 125
2019
Q4 		$428K Buy
3,956
+3,369
+574% +$360K 0.42% 88
2019
Q3 		$58K Buy
587
+559
+1,996% +$63K 0.06% 240
2019
Q2 		$4K Sell
28
-702
-96% -$90.5K ﹤0.01% 402
2019
Q1 		$99K Buy
730
+216
+42% +$26.9K 0.12% 181
2018
Q4 		$50K Buy
514
+460
+852% +$54.4K 0.09% 188
2018
Q3 		$8K Buy
+54
New +$6.77K 0.01% 261
2014
Q3 		– Sell
-1,396
Closed -$219K – 361
2014
Q2 		$219K Buy
1,396
+860
+160% +$136K 0.56% 70
2014
Q1 		$82K Buy
536
+510
+1,962% +$81.1K 0.24% 142
2013
Q4 		$3K Sell
26
-15
-37% -$1.8K ﹤0.01% 280
2013
Q3 		$5K Sell
41
-22
-35% -$2.41K ﹤0.01% 286
2013
Q2 		$6K Buy
+63
New +$6.07K 0.01% 282

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return

NuWave Investment Management's ALXN Position: Q2 2021 in Review

NuWave Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q2 2021, closing a stake of 4,127 shares — an estimated $631K sold.

NuWave Investment Management first reported a position in ALXN in Q2 2013 and held it in 15 quarters. The position peaked at $631K in Q1 2021. 710 funds tracked by Wall St. Rank hold ALXN as of Q2 2021.

  • NuWave Investment Management reported no remaining Alexion Pharmaceuticals position as of Q2 2021 after selling out during the quarter.
  • NuWave Investment Management sold 4,127 Alexion Pharmaceuticals shares in Q2 2021, an estimated $631K.
  • NuWave Investment Management first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 15 quarters.
  • NuWave Investment Management's Alexion Pharmaceuticals position peaked at $631K in Q1 2021.
  • 710 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q2 2021.

Based on NuWave Investment Management's 13F filing for Q2 2021, filed 16 Jul 2021.